I
IMP
vs
ROG
ROG
Over the past 12 months, IMP has underperformed ROG, delivering a return of +20% compared to the ROG's +26% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ROG
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
I
|
Imexpharm Corp
VN:IMP
|
53 600
VND
|
|||||
|
Roche Holding AG
SIX:ROG
|
346.9
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
IMP, ROG
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
I
|
Imexpharm Corp
Revenue
|
|||||||||||
|
Roche Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
IMP, ROG
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
I
|
Imexpharm Corp
VN:IMP
|
|||||||||
|
Roche Holding AG
SIX:ROG
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
IMP, ROG
Performance Gap
IMP, ROG
Performance By Year
IMP, ROG
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.